Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts

Journal of Cellular Biochemistry

Volumn 98, Issue 5, 2006, Pages 1123-1129

  Lamghari, M ^a   Tavares, L ^a   Camboa, N ^a   Barbosa, M A ^a  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Leptin; MC3T3 E1; Ob Ra; Ob Rb; OPG; Osteoblasts; RANKL

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR A; LEPTIN RECEPTOR B; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HORMONE ACTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ALKALINE PHOSPHATASE; ANIMALS; CARRIER PROTEINS; CELL LINE; GENE EXPRESSION; GLYCOPROTEINS; LEPTIN; MEMBRANE GLYCOPROTEINS; MICE; OSTEOBLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 33746452603     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20853     Document Type: Article

References (28)

1. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT. 2001. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546-3553.
2. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR. 2002. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415.
3. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207.
4. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520.
5. Elmquist JK. 2001. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav 74:703-708.
6. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. 2002. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825-836.
7. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC. 2002. Leptin inhibits osteoclast generation. J Bone Miner Res 17:200-209.
8. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
9. Kanematsu M, Yoshimura K, Takaoki M, Sato A. 2002. Vector-averaged gravity regulates gene expression of receptor activator of NF-κB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. Bone 30:553-558.
10. Lacely DL, Timms E, Tan HL, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoproteferin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-167.
11. Lee SK, Lorenzo JA. 1999. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation. Endocrinology 140:3552-3561.
12. Lee SK, Lorenzo JA. 2002a. Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone 31:252-259.
13. Lee YJ, Park JH, Ju SK, You KH, Ko JS, Kim HM. 2002b. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett 528:43-47.
14. Liu J, Yang H, Liu W, Cao X, Feng X. 2005. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem 96(4):716-727.
15. Martin A, de Vittoris R, David V, Moraes R, Bégeot M, Lafage-Proust MH, Alexandre C, Vico L, Thomas T. 2005. Leptin modulates both résorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology 146:3652-3659.
16. Nagai M, Sato N. 1999. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Commun 257:719-723.
17. Nakajima R, Inada H, Koike T, Yamano T. 2003. Effects of leptin to cultured growth plate chondrocytes. Horm Res 60(2):91-98.
18. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. 2001. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88(9):954-960.
19. Reseland JE, Syversen U, Bakke I, Ovigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA. 2001. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426-1414.
20. Rubin J, Ackert-Bicknell C, Zhu L, Fan X, Murphy T, Nanes M, Marcus R, Holloway L, Beamer W, Rosen C. 2002a. Insulin like growth factor-I (IGF-I) regulates osteoprotegerin (OPG) and RANK ligand (RANKL) in vitro and osteoprotogerin in vivo. J Clin Endocrinal Metab 87:4273-4279.
21. Rubin J, Murphy T, Fan X, Goldschmidt M, Taylor W. 2002b. Mechanical strain inhibits RANKL expression through activation of ERK1/2 in bone marrow stromal cells. J Bone Miner Res 17:1452-1460.
22. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
23. Steppan CM, Crawford T, Chidsey-Frink KL, Ke HZ, Swick AG. 2000. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73-78.
24. Suda T, Ueno Y, Fujii K, Shinki T. 2003. Vitamin D and bone. J Cell Biochem 88:259-266.
25. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. 1999. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630-1638.
26. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T. 2000. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484.
27. Wamoto I, Fujino T, Douchi T. 2004. The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism. Gynecol Endocrinol 19:97-104.
28. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.